Series B Pharmaceutical Companies

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Our purpose is to make every pregnancy around the world safer.

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.

Holiferm develops holistically improved fermentation technology for massive economic improvements.

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Free Market Health is a healthcare technology company empowering payers and pharmacies with a care-driven marketplace platform.

Shorla Pharma is an Irish specialty pharmaceutical company.

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.